These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34220497)

  • 1. Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids.
    Li Q; Gao B; Siqin B; He Q; Zhang R; Meng X; Zhang N; Zhang N; Li M
    Front Pharmacol; 2021; 12():651926. PubMed ID: 34220497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
    Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
    Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interaction between Flavonoids and Intestinal Microbes: A Review.
    Xiong HH; Lin SY; Chen LL; Ouyang KH; Wang WJ
    Foods; 2023 Jan; 12(2):. PubMed ID: 36673411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases.
    Lu J; Jin X; Yang S; Li Y; Wang X; Wu M
    Front Microbiol; 2022; 13():1034537. PubMed ID: 36590426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
    Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
    Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening analysis of natural flavonoids as trimethylamine (TMA)-lyase inhibitors for coronary heart disease.
    Zhou P; Zhao XN; Ma YY; Tang TJ; Wang SS; Wang L; Huang JL
    J Food Biochem; 2022 Dec; 46(12):e14376. PubMed ID: 35945702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota.
    Wang M; Yu F; Zhang Y; Chang W; Zhou M
    Int J Biol Sci; 2022; 18(4):1451-1475. PubMed ID: 35280689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary flavonoids-microbiota crosstalk in intestinal inflammation and carcinogenesis.
    Wang L; Li M; Gu Y; Shi J; Yan J; Wang X; Li B; Wang B; Zhong W; Cao H
    J Nutr Biochem; 2024 Mar; 125():109494. PubMed ID: 37866426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota.
    Zhao X; Zhong X; Liu X; Wang X; Gao X
    Front Nutr; 2021; 8():693412. PubMed ID: 34164427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
    Zhu J; Lyu J; Zhao R; Liu G; Wang S
    Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids, gut microbiota, and host lipid metabolism.
    Zhou M; Ma J; Kang M; Tang W; Xia S; Yin J; Yin Y
    Eng Life Sci; 2024 May; 24(5):2300065. PubMed ID: 38708419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
    Sata Y; Marques FZ; Kaye DM
    Curr Hypertens Rep; 2020 May; 22(5):38. PubMed ID: 32385705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on gut microbiota in cardiovascular diseases.
    Qian B; Zhang K; Li Y; Sun K
    Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure.
    Cui H; Han S; Dai Y; Xie W; Zheng R; Sun Y; Xia X; Deng X; Cao Y; Zhang M; Shang H
    Phytomedicine; 2023 Aug; 117():154885. PubMed ID: 37302262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
    Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
    Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota in Cardiovascular Health and Disease.
    Tang WH; Kitai T; Hazen SL
    Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine organs of cardiovascular diseases: Gut microbiota.
    Jia Q; Xie Y; Lu C; Zhang A; Lu Y; Lv S; Zhang J
    J Cell Mol Med; 2019 Apr; 23(4):2314-2323. PubMed ID: 30688023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Intestinal Microbiota on the Catabolism of Flavonoids in Mice.
    Lin W; Wang W; Yang H; Wang D; Ling W
    J Food Sci; 2016 Dec; 81(12):H3026-H3034. PubMed ID: 27792839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.